Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health Marketable Equity Securities — Fair Value by Quarter
Marketable Equity Securities — Fair Value ($M)
Elevance Health Marketable Equity Securities — Fair Value: $2,151M in Q3 2026, up 76.3% from a year earlier.
Latest, Q3 2026
2,151
Period ended Sep 30, 2026
Change on a year earlier
+76.3%
1,220 in Q3 2025
History
29 quarters
Since Q4 2018
Sources
3
Documents cited below
Where the Q3 2026 figure comes from
“us-gaap:EquitySecuritiesFvNi (2026-09-30): 2,151,000,000.00”
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Elevance Health Marketable Equity Securities — Fair Value ($M), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv-equity-securities-fv
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.